# A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

> **NCT05636176** · PHASE3 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 5600 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Ziltivekimab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05636176
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-08
- **Primary completion:** 2027-07-02
- **Final completion:** 2027-07-02
- **Target enrollment:** 5600 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05636176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05636176, "A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05636176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*